IBM Watson™ Genomics from Quest Diagnostics®: with knowing comes hope
Just as no two patients are alike, no two cancers are alike, either. Especially for patients with rare, aggressive, or late-stage disease, cancer treatment options may be limited or seem nonexistent. IBM Watson Genomics from Quest Diagnostics may change that. It combines state-of-the-art tumor sequencing with powerful cancer data analysis. This can quickly uncover highly personalized cancer treatment options—including options that previously may have remained unidentified.
Employing massive amounts of data and powerful cognitive computing, Watson Genomics from Quest Diagnostics gives patients and their physicians a new weapon in the fight against cancer. It’s the power of knowing more, sooner. And with knowing comes hope.